FLETA BOLUS
Main information
- Trade name:
- FLETA BOLUS 10ML V. INJ
- Active ingredient:
- EPTIFIBATIDE
- Available from:
- Lupin
- Dosage:
- 2MG/ML
- Pharmaceutical form:
- INJ
- Composition:
- 10ML V.
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
3-5-2017
Human medicines European public assessment report (EPAR): Integrilin, eptifibatide, Revision: 21, Authorised
Europe - EMA - European Medicines Agency
6-4-2018
![MAGMILAX BOLUS (Magnesium Oxide) Tablet [Vedco, Inc.]](/web/assets/global/img/flags/us.png)
MAGMILAX BOLUS (Magnesium Oxide) Tablet [Vedco, Inc.]
Updated Date: Apr 6, 2018 EST
US - DailyMed
20-3-2018
Integrilin (Glaxo Group Ltd)
Integrilin (Active substance: Eptifibatide) - Centralised - Yearly update - Commission Decision (2018)1742 of Tue, 20 Mar 2018
Europe -DG Health and Food Safety
28-2-2018
RUMEN BOLUS (Magnesium Oxide) Tablet [Durvet, Inc.]
Updated Date: Feb 28, 2018 EST
US - DailyMed
27-2-2018
MVT BOLUS (Magnesium Oxide) Tablet [Henry Schein Animal Health]
Updated Date: Feb 27, 2018 EST
US - DailyMed
19-1-2018
ENDOSORB BOLUS (Attapulgite, Kaolin, Carob, Citrus Pectin, Magnesium Trisilicate) Tablet [Pegasus Laboratories, Inc.]
Updated Date: Jan 19, 2018 EST
US - DailyMed
12-1-2018
EPTIFIBATIDE Injection, Solution [Akorn, Inc.]
Updated Date: Jan 12, 2018 EST
US - DailyMed
14-12-2017
I.O.DINE COMPLEX BOLUS (Povidone-Iodine) Tablet, For Solution [Pegasus Laboratories, Inc.]
Updated Date: Dec 14, 2017 EST
US - DailyMed
29-11-2017
OXY 500 CALF BOLUS (Oxytetracycline Hydrochloride) Tablet [Boehringer Ingelheim Vetmedica, Inc.]
Updated Date: Nov 29, 2017 EST
US - DailyMed
10-8-2017
SUSTAIN III CALF BOLUS (Sulfamethazine Sustained Release Calf Bolus) Tablet, Extended Release [Durvet]
Updated Date: Aug 10, 2017 EST
US - DailyMed
23-6-2017
ASPIRIN BOLUS (Acetylsalicylic Acid) Tablet [MWI Veterinary Supply, Inc.]
Updated Date: Jun 23, 2017 EST
US - DailyMed
19-6-2017
EPTIFIBATIDE Injection [AuroMedics Pharma LLC]
Updated Date: Jun 19, 2017 EST
US - DailyMed
15-6-2017
Single-Shot IDegLira Bests Basal-Bolus Insulin Regimen in Diabetes
A single daily injection of fixed-dose insulin degludec/liraglutide (IDegLira) (Xultophy 100/3.6, Novo Nordisk) could offer an alternative to multiple daily insulin injections for patients with type 2 diabetes who don't achieve glucose targets with basal insulin alone, new company-sponsored research shows.
US - RxList
18-1-2016
Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Revision: 0, Authorised
Europe - EMA - European Medicines Agency